FGA
GH icon

Fortis Group Advisors’s Guardant Health GH Stock Holding History

Fortis Group Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$883K Buy
+7,907
New +$723K 0.17% 69

Other funds holding GH

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Fortis Group Advisors's GH Position: Q3 2020 in Review

Fortis Group Advisors opened a new position in Guardant Health (GH) in Q3 2020: 7,907 shares worth $883K. The stake represents 0.17% of the portfolio and ranks #69 among its holdings.

346 funds tracked by Wall St. Rank hold GH as of Q3 2020.

  • Fortis Group Advisors held 7,907 shares of Guardant Health worth $883K as of Q3 2020.
  • Guardant Health was a new Fortis Group Advisors position in Q3 2020.
  • Guardant Health made up 0.17% of Fortis Group Advisors's portfolio in Q3 2020, its #69 holding.
  • 346 funds tracked by Wall St. Rank held Guardant Health as of Q3 2020.

Based on Fortis Group Advisors's 13F filing for Q3 2020, filed 17 Nov 2020.